| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes
|
Yao, Chi-Yuan
|
|
|
1 |
19 |
p. 1505-1516
|
artikel
|
| 2 |
A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma
|
Chari, Ajai
|
|
|
1 |
19 |
p. 1575-1583
|
artikel
|
| 3 |
Co-occurrence of FLT3-TKD and NPM1 mutations defines a highly favorable prognostic AML group
|
Boddu, Prajwal
|
|
|
1 |
19 |
p. 1546-1550
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
1 |
19 |
p. i
|
artikel
|
| 5 |
Erythropoiesis-stimulating agents in elderly patients with anemia: response and cardiovascular outcomes
|
Gowanlock, Zachary
|
|
|
1 |
19 |
p. 1538-1545
|
artikel
|
| 6 |
Fibrin and D-dimer bind to monomeric GPVI
|
Onselaer, Marie-Blanche
|
|
|
1 |
19 |
p. 1495-1504
|
artikel
|
| 7 |
IAPs protect host target tissues from graft-versus-host disease in mice
|
Toubai, Tomomi
|
|
|
1 |
19 |
p. 1517-1532
|
artikel
|
| 8 |
Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?
|
Schwab, Claire
|
|
|
1 |
19 |
p. 1473-1477
|
artikel
|
| 9 |
Jayappa KD, Portell CA, Gordon VL, et al. Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL. Blood Adv. 2017;1(14):933-946.
|
|
|
|
1 |
19 |
p. 1537
|
artikel
|
| 10 |
Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screening
|
Luskin, Marlise R.
|
|
|
1 |
19 |
p. 1491-1494
|
artikel
|
| 11 |
MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugs
|
Maifrede, Silvia
|
|
|
1 |
19 |
p. 1467-1472
|
artikel
|
| 12 |
Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib
|
Miller, Cecelia R.
|
|
|
1 |
19 |
p. 1584-1588
|
artikel
|
| 13 |
Patient-centered care coordination in hematopoietic cell transplantation
|
Khera, Nandita
|
|
|
1 |
19 |
p. 1617-1627
|
artikel
|
| 14 |
Patient-derived antibody recognizes a unique CD43 epitope expressed on all AML and has antileukemia activity in mice
|
Gillissen, Marijn A.
|
|
|
1 |
19 |
p. 1551-1564
|
artikel
|
| 15 |
Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review
|
Sins, Joep W.R.
|
|
|
1 |
19 |
p. 1598-1616
|
artikel
|
| 16 |
Platelet dense granules begin to selectively accumulate mepacrine during proplatelet formation
|
Hanby, Hayley A.
|
|
|
1 |
19 |
p. 1478-1490
|
artikel
|
| 17 |
Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis
|
Broglie, Larisa
|
|
|
1 |
19 |
p. 1533-1536
|
artikel
|
| 18 |
The impact of von Willebrand factor on factor VIII memory immune responses
|
Chen, Juan
|
|
|
1 |
19 |
p. 1565-1574
|
artikel
|
| 19 |
The number of CD56dim NK cells in the graft has a major impact on risk of disease relapse following allo-HSCT
|
Maggs, Luke
|
|
|
1 |
19 |
p. 1589-1597
|
artikel
|
Tijdschrift beschrijving